Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

The study concluded that examining the scalp with a special magnifying device helps diagnose the cause of widespread hair loss in adult women.

A new genetic mutation in the CDH3 gene causes hair loss and eye problems in young people.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Circular RNA ERCC6 helps activate stem cells important for cashmere goat hair growth by interacting with specific molecules in an m6A modification-dependent way.

308 nm excimer lamp therapy is effective for alopecia areata but less so for severe cases.

Ruxolitinib treatment may cause eyelash growth.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Reduced matriptase activity causes skin and hair issues in both humans and mice.

CAL-PDT is safer and more effective for treating actinic keratosis on the scalp.

A committee was formed to improve hair restoration for certain hair diseases by collecting and analyzing data.

Morroniside may help hair grow and stay in its growth phase by affecting certain cell signals.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

New nanoparticles deliver plant extracts to hair follicles to treat conditions like hair loss and acne.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Understanding patients' views on their illness can help improve their disease management.

EREG therapy may help treat hair loss by promoting hair growth.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.